Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Horn Kinney Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Horn Kinney (CHIEF BUSINESS OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns: Disposed/sold 5,251 shares @ $0
Exercised 5,251 options to buy @ $2.064, valued at $10.8k
01/11/2022 4 Horn Kinney (CHIEF BUSINESS OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns: Sold 5,251 shares @ $6.85, valued at $36k
Exercised 5,251 options to buy @ $2.064, valued at $10.8k
12/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2021 4 Horn Kinney (CHIEF BUSINESS OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns: Sold 27,668 shares @ $26.88, valued at $743.7k
Exercised 5,251 options to buy @ $2.064, valued at $10.8k
Exercised 22,417 options to buy @ $19, valued at $425.9k
10/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2020 4 Horn Kinney (Chief Business Officer) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns: Granted 252,060 options to buy @ $2.064, valued at $520.3k
Granted 89,670 options to buy @ $19, valued at $1.7M
11/18/2020 3 Horn Kinney (Chief Business Officer) has filed a Form 3 on Olema Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy